{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:05:43Z","timestamp":1791299143280,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T00:00:00Z","timestamp":1498262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council of Taiwan","doi-asserted-by":"publisher","award":["NSC-100\u20132314-B-384\u2013002"],"award-info":[{"award-number":["NSC-100\u20132314-B-384\u2013002"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chi-Mei Medical Center Research Foundation","award":["CMFHT10202, CMFHR10412"],"award-info":[{"award-number":["CMFHT10202, CMFHR10412"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jmii.2016.12.008","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T15:03:24Z","timestamp":1499353404000},"page":"931-939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance"],"prefix":"10.1016","volume":"50","author":[{"given":"Yee-Huang","family":"Ku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Feng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ching","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7345-800X","authenticated-orcid":false,"given":"Wen-Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2016.12.008_bib1","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteremia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systemic review and meta-analysis","volume":"67","author":"Varjakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib2","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia","volume":"60","author":"Tamma","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2016.12.008_bib3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1086\/598244","article-title":"Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns","volume":"30","author":"Hussein","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jmii.2016.12.008_bib4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/AAC.01235-09","article-title":"In\u00a0vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those non-susceptible to tigecycline and\/or colistin","volume":"54","author":"Edimiani","year":"2010","journal-title":"Amtimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","article-title":"What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2016.12.008_bib6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ajic.2011.12.014","article-title":"Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and\/or carbapenem-resistant Enterobacteriaceae infections","volume":"40","author":"Ku","year":"2012","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jmii.2016.12.008_bib7","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/jac\/dkq346","article-title":"Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli","volume":"65","author":"Oteo","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12879-015-0996-7","article-title":"Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 to December 2014","volume":"15","author":"Parisi","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2016.12.008_bib9","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1128\/AAC.00827-13","article-title":"Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae","volume":"57","author":"Nigo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib10","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2165\/11315690-000000000-00000","volume":"69","author":"Giamarellou","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.jmii.2016.12.008_bib11","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.jmii.2016.12.008_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1684-1182(10)60004-7","article-title":"Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods","volume":"43","author":"Su","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2016.12.008_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: the versatile \u03b2-lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2016.12.008_bib14","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/AAC.48.4.1249-1255.2004","article-title":"Dissemination of CTX-M-Type \u03b2-lactamases among clinical isolates of Enterobacteriaceae in Paris, France","volume":"48","author":"Eckert","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib15","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/AAC.01247-10","article-title":"Detection of NDM-1-producing Klebsiella pneumoniae in Kenya","volume":"55","author":"Poirel","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib16","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1128\/AAC.01275-10","article-title":"Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence","volume":"55","author":"Tsai","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib17","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/jac\/dku065","article-title":"In\u00a0vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates","volume":"69","author":"Gaibani","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib18","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1128\/AAC.38.9.2065","article-title":"Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology","volume":"38","author":"Pankuch","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib19","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/jcm.32.10.2553-2558.1994","article-title":"Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 \u03b2-lactamase and which were isolated in 14 French hospitals","volume":"32","author":"Arlet","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2016.12.008_bib20","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1128\/AAC.01301-09","article-title":"An ertapenem-resistant extended-spectrum-\u03b2-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant","volume":"54","author":"Garc\u00eda-Fern\u00e1ndez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/mdr.2010.0115","article-title":"Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital","volume":"17","author":"Wu","year":"2011","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jmii.2016.12.008_bib22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/AAC.01222-13","article-title":"Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence","volume":"58","author":"Falagas","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11908-015-0493-6","article-title":"Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance","volume":"17","author":"Liang","year":"2015","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jmii.2016.12.008_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jmii.2013.11.005","article-title":"In\u00a0vitro activity of colistin sulfate against Enterobacteriaceae producing extended-spectrum \u03b2-lactamases","volume":"48","author":"Ku","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2016.12.008_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1179\/1973947813Y.0000000143","article-title":"Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline\/colistin combination","volume":"26","author":"Demirasian","year":"2014","journal-title":"J Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib26","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1128\/AAC.00891-13","article-title":"Activity of tigecycline in combination with colistin, meropenem, rifampin, gentamicin against KPC-producing Enterobacteriaceae in a murine thigh model","volume":"57","author":"Michail","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.12.008_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bjid.2016.09.008","article-title":"Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae","volume":"21","author":"Tuon","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jmii.2016.12.008_bib28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10096-011-1360-5","article-title":"Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates","volume":"31","author":"Samonis","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2016.12.008_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diagmicrobio.2013.04.004","article-title":"In\u00a0vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA-48-positive Klebsiella pneumoniae strains","volume":"76","author":"Evren","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2016.12.008_bib30","first-page":"671","article-title":"Preliminary study of the antagonistic effects between fosfomycin and beta-lactams on Pseudomonas aeruginosa observed on the antibiogram","volume":"36","author":"Buisson","year":"1988","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.jmii.2016.12.008_bib31","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/cc13858","article-title":"High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria","volume":"18","author":"De Pascale","year":"2014","journal-title":"Crit Care"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217300907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217300907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:20:49Z","timestamp":1761657649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118217300907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1684118217300907"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2016.12.008","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2016.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}